Genuine Latisse - $49 each when you buy 2

bimatoprost, Latisse, Lumigan

April 30, 2009 · Posted in Health News · Comments Off 

Title: bimatoprost, Latisse, LumiganCategory: MedicationsCreated: 5/1/2009Last Editorial Review: 5/1/2009 (Source: MedicineNet Medications General)

See original here:
bimatoprost, Latisse, Lumigan

FDA Approves Allergan’s Drug for Longer Eyelashes

December 29, 2008 · Posted in Health News · Comments Off 

Allergan Inc, maker of Botox, said on Friday that the U.S.

Link:
FDA Approves Allergan’s Drug for Longer Eyelashes

Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

December 29, 2008 · Posted in Health News · Comments Off 

IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc.

Read the original:
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

December 27, 2008 · Posted in Health News · Comments Off 

New prescription drug Latisse increases the length, thickness and darkness of eyelashes. (Source: Huliq Health News)

See the original post here:
FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment

Allergan Eyelash Enhancer Approved

December 27, 2008 · Posted in Health News · Comments Off 

Allergan received FDA approval to market Latisse, a beauty treatment that increases the length, thickness and darkness of eyelashes by using a drug the company developed to treat glaucoma.

See more here:
Allergan Eyelash Enhancer Approved

Allergan Gets Nod For Eyelash Treatment

December 26, 2008 · Posted in Health News · Comments Off 

Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,… (Source: Investor’s Business Daily: HEALTH)

More:
Allergan Gets Nod For Eyelash Treatment

FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

December 8, 2008 · Posted in Health News · Comments Off 

IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve Latisse..

See the original post here:
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

« Previous Page